Journal of Molecular Pathology | Highly Cited Papers in 2021

All of the articles published in Journal of Molecular Pathology (JMP, ISSN: 2673-5261) are in an open access format, granting our readers free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2021, which are listed below:

1. “Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective”
by Umberto Malapelle, Marcello Tiseo, Ana Vivancos, Joshua Kapp, M. Josè Serrano and Markus Tiemann
J. Mol. Pathol. 2021, 2(3), 255-273; https://doi.org/10.3390/jmp2030022
Available online: https://www.mdpi.com/2673-5261/2/3/22

2. “Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer”
by Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Gianluca Gragnano, Elalah Mosaieby, Giancarlo Troncone and Umberto Malapelle
J. Mol. Pathol. 2021, 2(3), 241-254; https://doi.org/10.3390/jmp2030021
Available online: https://www.mdpi.com/2673-5261/2/3/21

3. “What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy”
by Paul Hofman
J. Mol. Pathol. 2021, 2(2), 147-172; https://doi.org/10.3390/jmp2020015
Available online: https://www.mdpi.com/2673-5261/2/2/15

4. “Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guidelines from the College of American Pathologists (CAP)”
by Sinchita Roy-Chowdhuri
J. Mol. Pathol. 2021, 2(1), 23-28; https://doi.org/10.3390/jmp2010003
Available online: https://www.mdpi.com/2673-5261/2/1/3

5. “PIK3CA Mutation Assessment in HR+/HER2− Metastatic Breast Cancer: Overview for Oncology Clinical Practice”
by Carmen Criscitiello, Antonio Marra and Giuseppe Curigliano
J. Mol. Pathol. 2021, 2(1), 42-54; https://doi.org/10.3390/jmp2010005
Available online: https://www.mdpi.com/2673-5261/2/1/5

6. “Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States”
by Michiya Nishino, Claudio Bellevicine and Zubair Baloch
J. Mol. Pathol. 2021, 2(2), 135-146; https://doi.org/10.3390/jmp2020014
Available online: https://www.mdpi.com/2673-5261/2/2/14

7. “Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel”
by Marta Vives-Usano, Beatriz García Pelaez, Ruth Román Lladó, Mónica Garzón Ibañez, Erika Aldeguer, Sonia Rodriguez, Andrés Aguilar, Francesc Pons, Santiago Viteri, Carlos Cabrera et al.
J. Mol. Pathol. 2021, 2(2), 123-134; https://doi.org/10.3390/jmp2020013
Available online: https://www.mdpi.com/2673-5261/2/2/13

8. “Clinical and Molecular Features of Anti-CENP-B Autoantibodies”
by Rahul M. Prasad, Alfonso Bellacosa and Tim J. Yen
J. Mol. Pathol. 2021, 2(4), 281-295; https://doi.org/10.3390/jmp2040024
Available online: https://www.mdpi.com/2673-5261/2/4/24

9. “Challenges of ICC and FISH in the Field of Targeted Therapies from Cell Block to Smears”
by Jose I. Echeveste, Tania Labiano, Eva Tejerina, Allan Argueta, Carlos de Andrea and Maria D. Lozano
J. Mol. Pathol. 2021, 2(2), 55-65; https://doi.org/10.3390/jmp2020006
Available online: https://www.mdpi.com/2673-5261/2/2/6

10. “Thyroid and Molecular Testing. Advances in Thyroid Molecular Cytopathology”
by Esther Diana Rossi and Philippe Vielh
J. Mol. Pathol. 2021, 2(2), 77-92; https://doi.org/10.3390/jmp2020008
Available online: https://www.mdpi.com/2673-5261/2/2/8